Apollo Hospitals Enterprise Limited carries a market capitalization of 1.28T, placing it among publicly traded companies globally. Its enterprise value stands at 1.12T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.28T |
| Enterprise Value | 1.12T |
Apollo Hospitals Enterprise Limited trades at a trailing price-to-earnings ratio of 70.89.
| PE Ratio | 70.89 |
| PS Ratio | 4.95 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Apollo Hospitals Enterprise Limited trades at an EV/EBITDA multiple of 46.40 and an EV/FCF ratio of 332.90. The EV/Sales ratio of 4.95 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 46.40 provides insight into valuation relative to core operating earnings.
| EV / Sales | 4.95 |
| EV / EBITDA | 46.40 |
| EV / EBIT | 46.40 |
| EV / FCF | 332.90 |
Apollo Hospitals Enterprise Limited maintains a current ratio of 3.00, meaning it holds 3.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 155.76, indicating elevated leverage, while an interest coverage ratio of 5.34 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 3.00 |
| Quick Ratio | 1.13 |
| Debt / Equity | 155.76 |
| Debt / EBITDA | N/A |
| Interest Coverage | 5.34 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | N/A |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 35.74 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, Apollo Hospitals Enterprise Limited has paid 5.61B in income taxes, reflecting an effective tax rate of 25.60.
| Income Tax | 5.61B |
| Effective Tax Rate | 25.60 |
Apollo Hospitals Enterprise Limited's stock has gained approximately 16.76964% over the past 52 weeks. The 50-day moving average sits at 8,243.57, while the 200-day moving average is 7,632.22.
| Beta (5Y) | N/A |
| 52-Week Price Change | 16.76964% |
| 50-Day Moving Average | 8,243.57 |
| 200-Day Moving Average | 7,632.22 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Apollo Hospitals Enterprise Limited generated 225.51B in revenue and converted that into 15.74B in net income, yielding earnings per share of 105.88. EBITDA reached 24.04B, while operating income came in at 24.04B.
| Revenue | 225.51B |
| Gross Profit | 108.16B |
| Operating Income | 24.04B |
| Pretax Income | 21.92B |
| Net Income | 15.74B |
| EBITDA | 24.04B |
| EBIT | 24.04B |
| Earnings Per Share (EPS) | 105.88 |
Apollo Hospitals Enterprise Limited operates with a gross margin of 47.96, reflecting its pricing power and cost economics. The operating margin of 10.66 and net profit margin of 6.98 provide insight into operational efficiency.
| Gross Margin | 47.96 |
| Operating Margin | 10.66 |
| Pretax Margin | 9.72 |
| Profit Margin | 6.98 |
| EBITDA Margin | 10.66 |
Apollo Hospitals Enterprise Limited's most recent stock split took place on September 2, 2010 with a 1:2 split ratio.
| Last Split Date | 9/2/2010 |
| Split Ratio | 1:2 |
Apollo Hospitals Enterprise Limited posts an Altman Z-Score of 15.02, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 15.02 |